Synergetic Neuroprotection of Normobaric Oxygenation and Ethanol in Ischemic Stroke Through Improved Oxidative Mechanism
Authors:
- Paul FuPFPaul Fu
- Xunming JiXunming Ji
- Changya PengCPChangya Peng
- Vance FredricksonVFVance Fredrickson
- Christopher SyCSChristopher Sy
- Ran MengRan Meng
- Feng LingFLFeng Ling
- Huishan DuHDHuishan Du
- Xiaomu TanXTXiaomu Tan
- Maik HüttemannMaik Hüttemann
- Murali GuthikondaMGMurali Guthikonda
- 1 May 2013
- journal article
- retracted article
- Published by Wolters Kluwer Health in Stroke
- Vol. 44 (5) , 1418-1425
Abstract
Background and Purpose—: Normobaric oxygenation (NBO) and ethanol both provide neuroprotection in stroke. We evaluated the enhanced neuroprotective effect of combining these 2 treatments in a rat stroke model. Methods—: Sprague-Dawley rats were subjected to middle cerebral artery occlusion for 2 hours. Reperfusion was then established and followed by treatment with either (1) an intraperitoneal injection of ethanol (1.0 g/kg), (2) NBO treatment (2-hour duration), or (3) NBO plus ethanol. The extent of brain injury was determined by infarct volume and motor performance. Oxidative metabolism was determined by ADP/ATP ratios, reactive oxygen species levels, nicotinamide adenine dinucleotide phosphate oxidase activity, and pyruvate dehydrogenase activity. Protein expression of major nicotinamide adenine dinucleotide phosphate oxidase subunits (p47 phox , gp91 phox , and p67 phox ) and the enzyme pyruvate dehydrogenase was evaluated through Western immunoblotting. Results—: NBO and ethanol monotherapies each demonstrated reductions as compared to stroke without treatment in infarct volume (36.7% and 37.9% vs 48.4%) and neurological deficits (score of 6.4 and 6.5 vs 8.4); however, the greatest neuroprotection (18.8% of infarct volume and 4.4 neurological deficit) was found in animals treated with combination therapy. This neuroprotection was associated with the largest reductions in ADP/ATP ratios, reactive oxygen species levels, and nicotinamide adenine dinucleotide phosphate oxidase activity, and the largest increase in pyruvate dehydrogenase activity. Conclusions—: Combination therapy with NBO and ethanol enhances the neuroprotective effect produced by each therapy alone. The mechanism behind this synergistic action is related to changes in cellular metabolism after ischemia reperfusion. NBO plus ethanol is attractive for clinical study because of its ease of use, tolerability, and tremendous neuroprotective potential in stroke.Keywords
This publication has 42 references indexed in Scilit:
- NADPH oxidase in stroke and cerebrovascular diseaseNeurological Research, 2012
- Neuroprotective Effect of Acute Ethanol Administration in a Rat With Transient Cerebral IschemiaStroke, 2012
- Alcohol in Moderation, Cardioprotection, and Neuroprotection: Epidemiological Considerations and Mechanistic StudiesAlcohol, Clinical and Experimental Research, 2009
- Normobaric hyperoxia attenuates early blood–brain barrier disruption by inhibiting MMP‐9‐mediated occludin degradation in focal cerebral ischemiaJournal of Neurochemistry, 2009
- Normobaric hyperoxia inhibits NADPH oxidase‐mediated matrix metalloproteinase‐9 induction in cerebral microvessels in experimental strokeJournal of Neurochemistry, 2008
- Sites of generation of reactive oxygen species in homogenates of brain tissue determined with the use of respiratory substrates and inhibitorsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2008
- Experimental models, neurovascular mechanisms and translational issues in stroke researchBritish Journal of Pharmacology, 2008
- A Pilot Study of Normobaric Oxygen Therapy in Acute Ischemic StrokeStroke, 2005
- Effects of Normobaric Hyperoxia in a Rat Model of Focal Cerebral Ischemia—ReperfusionJournal of Cerebral Blood Flow & Metabolism, 2002
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985